BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Reuters

02/28

Feb 28 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY:

UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER
UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV

Source text: [ID:]

Further company coverage: MRNA.O

((Reuters.Briefs@thomsonreuters.com;))

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2514901344"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514901344\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514901344?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 18:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514901344","market":"nz","top_or_hot":-1,"title":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title></head><body><p><span>Feb 28 (Reuters)</span><span> - </span>MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: </p><ul><li><p>UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER</p></li><li><p>UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: <span>MRNA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-02-28 18:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title></head><body><p><span>Feb 28 (Reuters)</span><span> - </span>MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: </p><ul><li><p>UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER</p></li><li><p>UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: <span>MRNA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0VV:1","article_id":"2514901344","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514901344","pubTimestamp":1740739049,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28  - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4501":"段永平概念","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4568":"美国抗疫概念","BK4588":"碎股","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","MRNA":"Moderna, Inc."},"translate_title":"简报-英国MHRA表示mRESVIA RSV疫苗获准保护60岁及以上患者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}